Synthetic Biologics competitorsClear all

Synthetic Biologics's top competitors include Vertex Pharmaceuticals, JanOne and MyoKardia.
Synthetic Biologics
Synthetic Biologics
Synthetic Biologics is a late-stage clinical company developing therapeutics designed to preserve the microbiome.
Vertex Pharmaceuticals
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
JanOne
JanOne
JanOne (formerly known as ARCA) is a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties.
MyoKardia
MyoKardia
MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.
Founding Date
Founding Date
2001
Founding Date
1989
Founding Date
2019
Founding Date
2012
Type
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Rockville, US HQ
Locations
Boston, US HQ
St Leonards, AU
Wien, AT
Toronto, CA
see more
Locations
Las Vegas, US HQ
Locations
South San Francisco, US HQ
Brisbane, US
Employees
Employees
1115% decrease
Employees
3,00020% increase
Employees
20835% increase
Employees
23542% increase
Valuation ($)
Valuation ($)
7.1 m
Valuation ($)
55.1 b
Valuation ($)
7.8 m
Valuation ($)
11.9 b
Twitter followers
Twitter followers
1.3 k
Twitter followers
64.7 k
Twitter followers
175
Twitter followers
1.1 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
14
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
9
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
19.6
Average likes per tweet (last 30 days)
3
Average likes per tweet (last 30 days)
8.4
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
92.86%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Alexa Website Rank
Alexa Website Rank
352754
Alexa Website Rank
145684
Alexa Website Rank
301301
Alexa Website Rank
239431
Employee Rating
Employee Rating
N/A
Employee Rating
3.3
Employee Rating
2.8
Employee Rating
4.2

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$4.2b (FY, 2019)
Revenue (est.)
$35.1m (FY, 2019)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$547.8m (FY, 2019)
Cost of goods
$27.3m (FY, 2019)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$3.6b (FY, 2019)
Gross profit
$7.8m (FY, 2019)
Gross profit
N/A
Net income
Net income
($15.3m) (FY, 2019)
Net income
$1.2b (FY, 2019)
Net income
($12m) (FY, 2019)
Net income
($276.2m) (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 16.1m
Total funding raised
$ 2.4m
Total funding raised
N/A
Total funding raised
$ 98m
For sources of this data, please see the company profile

View company profiles

Vertex Pharmaceuticals
HQ
Boston, US
Employees
3,000↑ 20% increase

Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.

View company
JanOne
HQ
Las Vegas, US
Employees
208↑ 35% increase

JanOne (formerly known as ARCA) is a company focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties.

View company
MyoKardia
HQ
South San Francisco, US
Employees
235↑ 42% increase

MyoKardia discovers, develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases.

View company